Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1906 AL 1920

Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation

Curtis MA, Low VF, Faull RL.

Dev Neurobiol. 2012 Jul;72(7):990-1005. doi: 10.1002/dneu.22028.

Danon disease caused by two novel mutations of the LAMP2 gene: implications for two ends of the clinical spectrum

Hong D, Shi Z, Wang Z, Yuan Y.

Clin Neuropathol. 2012 Jul-Aug;31(4):224-31. doi: 10.5414/NP300465.

Fall frequency and risk assessment in early Parkinson's disease

Voss TS, Elm JJ, Wielinski CL, Aminoff MJ, Bandyopadhyay D, Chou KL, Sudarsky LR, Tilley BC; Falls Writing Group NINDS NET-PD Investigators.

Parkinsonism Relat Disord. 2012 Aug;18(7):837-41. doi: 10.1016/j.parkreldis.2012.04.004. Epub 2012 Apr 26.

Protein-oxidized phospholipid interactions in cellular signaling for cell death: from biophysics to clinical correlations

Kinnunen PK, Kaarniranta K, Mahalka AK.

Biochim Biophys Acta. 2012 Oct;1818(10):2446-55. doi: 10.1016/j.bbamem.2012.04.008. Epub 2012 Apr 19.

Coenzyme Q10 deficiency in patients with Parkinson's disease

Mischley LK, Allen J, Bradley R.

J Neurol Sci. 2012 Jul 15;318(1-2):72-5. doi: 10.1016/j.jns.2012.03.023. Epub 2012 Apr 27.

Spatiotemporal variability during gait initiation in Parkinson's disease

Roemmich RT, Nocera JR, Vallabhajosula S, Amano S, Naugle KM, Stegemöller EL, Hass CJ.

Gait Posture. 2012 Jul;36(3):340-3. doi: 10.1016/j.gaitpost.2012.01.018. Epub 2012 Apr 27.

Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats

Korkmaz O, Ay H, Ulupinar E, Tunçel N.

J Mol Neurosci. 2012 Nov;48(3):565-73. doi: 10.1007/s12031-012-9781-x. Epub 2012 Apr 29.

Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?

Kanouchi T, Ohkubo T, Yokota T.

J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):739-45. doi: 10.1136/jnnp-2011-301826. Epub 2012 Apr 27.

Nightmare-enacting behavior responding to zonisamide in early Parkinson's disease

Kataoka H, Ueno S.

Case Rep Neurol. 2012 Jan;4(1):31-3. doi: 10.1159/000336441. Epub 2012 Jan 25.

Constipation--presenting compliant and clinical marker of Parkinson's disease

Rana AQ.

Bangladesh Med Res Counc Bull. 2012 Apr;38(1):41-2. doi: 10.3329/bmrcb.v38i1.10453.

Examining the mechanisms that link β-amyloid and α-synuclein pathologies

Marsh SE, Blurton-Jones M.

Alzheimers Res Ther. 2012 Apr 30;4(2):11. doi: 10.1186/alzrt109. eCollection 2012.

Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health

Rothman SM, Griffioen KJ, Wan R, Mattson MP.

Ann N Y Acad Sci. 2012 Aug;1264(1):49-63. doi: 10.1111/j.1749-6632.2012.06525.x. Epub 2012 Apr 30.

Parkinson disease and metabolic bone disorders: a common connection that needs more attention

Levin RM, Tucci JR.

Endocr Pract. 2012 Jul-Aug;18(4):591-4. doi: 10.4158/EP12020.CO.

Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers

Nyholm D, Lewander T, Gomes-Trolin C, Bäckström T, Panagiotidis G, Ehrnebo M, Nyström C, Aquilonius SM.

Clin Neuropharmacol. 2012 May-Jun;35(3):111-7. doi: 10.1097/WNF.0b013e31825645d1.

Oral aripiprazole-induced severe hypoglycemia

Mondal S, Saha I, Das S, Ganguly A, Ghosh A, Kumar Das A.

Ther Drug Monit. 2012 Jun;34(3):245-8. doi: 10.1097/FTD.0b013e3182557d10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias